VIP: Handling, Storage, and Reconstitution Guide

This VIP handling and storage guide covers lab best practice for vasoactive intestinal peptide. VIP is supplied as a freeze-dried research material. The guide covers reconstitution for in vitro work, cold-chain storage, aliquoting, and record keeping. It pays special attention to the lower stability of VIP once it is in solution. Every step below is lab procedure, not human-use instruction.

What are the basics of VIP handling and storage?

VIP ships as a solid, white, lyophilized powder in a sealed glass vial. Lyophilized means freeze-dried. Store the dry vial sealed at or below 25 degrees Celsius. Keep it away from heat, light, and moisture. For long storage, keep the vial lyophilized and refrigerated or frozen.

VIP is a 28-residue peptide. Its molecular formula is C147H237N43O43S, and its molecular weight is about 3326.83 g/mol. Handle it with standard peptide care:

• Limit contact with room humidity.
• Avoid warming the sealed vial again and again.
• Let a cold vial reach room temperature before opening, to reduce condensation.

These steps match general practice across the neuroregulatory peptides. The DSIP handling guide uses the same approach.

The 10 mg vial is supplied lyophilized because the dry solid holds up best in transit and storage. VIP is a larger, strongly basic peptide. So it is especially worth keeping sealed and dry, which preserves the stability of the dry form.

Log the condition of the vial on arrival and the storage temperature assigned to it. This gives a clean baseline if problems come up later.

How is VIP reconstituted for in vitro work?

For in vitro work, VIP is usually reconstituted with bacteriostatic water. A few simple steps help protect the peptide:

1. Add the water slowly down the vial wall, not onto the powder.
2. Swirl gently. Do not shake.
3. Allow a few minutes for the powder to dissolve fully.

Aiming the liquid at the glass reduces foaming and local shear stress. This matters for a peptide that is already less stable in solution.

The working concentration depends on the assay. It should follow the study design, not a fixed formula. Labs planning tests can revisit the VIP research applications to match concentration to the model.

Work under clean conditions with calibrated pipettes and suitable PPE, in line with institutional SOPs. Check that the solution is clear with no visible particles. Record the solvent, volume, and final concentration so the batch can be repeated. This is standard lab reagent preparation, not a route of administration.

How stable is reconstituted VIP, and how should it be aliquoted?

A key point for VIP is that the reconstituted peptide is less stable than the dry form. Prepare solution close to the time of use. Split it into single-use aliquots. This limits both breakdown and repeated freeze-thaw cycles.

Keep conditions steady for the whole study, and check storage records as part of quality control. Label each aliquot so it can be traced:

• Compound name and lot number.
• Reconstitution solvent and final concentration.
• Preparation date and assigned storage temperature.
• Storage location, for a cold chain that can be audited.

How is a VIP certificate of analysis checked?

Each VIP batch ships with a certificate of analysis, or COA, checked by a third party. It documents:

• Purity by HPLC or reverse-phase chromatography.
• Identity confirmed by mass spectrometry.
• Lot number, test date, and method details.

Record the lot number against test results. This ties the data back to a specific batch. Sample COAs can be requested before purchase to confirm test methods. Material and records are on the VIP product page.

Consistent handling and COA checks make the results in the VIP mechanism of action repeatable across runs. Teams handling other neuroregulatory peptides can compare notes with the Cerebrolysin handling guide. It follows similar cold-chain rules.

Reading the full COA is worth the effort. The purity value shows how much of the material is the intended peptide. The mass spectrometry result confirms identity against the expected mass of about 3326.83 g/mol.

Taken together, and logged against each dataset, these results let a lab make a sound quality claim for a batch. They also let the lab trace any result back to the material behind it.

Why do cold-chain and traceability matter for VIP?

Reconstituted VIP is less stable than the dry form. So cold-chain care is central for VIP, not a side issue.

Three habits limit the time the dissolved form has to break down:

• Hold the dry vial and any aliquots at their assigned temperatures.
• Keep time at room temperature short during handling.
• Prepare solution close to the time of use.

Log each transfer. This keeps the material in a known state from receipt to experiment.

Traceability completes the picture. Tie every aliquot to a lot number and a certificate of analysis. Keep those records with the raw data. Then results stay auditable long after the bench work ends.

The solution form of VIP is time-sensitive. So this record is what lets a lab tell a real signal apart from an artifact of aged material.

What safety and compliance steps apply to VIP?

Handle VIP as a research chemical. Only qualified staff should work with it. Use engineering controls where required. Dispose of it in line with institutional and applicable rules.

Reconstituted material is less stable. So keep storage conditions steady and records complete for the whole study. This supports both quality control and audit readiness.

For research use only. VIP is an investigational research peptide and is not approved for human or veterinary use. All handling guidance refers to laboratory procedure only.